Clinical outcomes after estimated versus calculated activity of radioiodine for the treatment of hyperthyroidism: systematic review and meta-analysis

Background: Despite the long experience with radioiodine for hyperthyroidism, controversy remains regarding the optimal method to determine the activity that is required to achieve long-term euthyroidism. Objectives: To compare the effect of estimated versus Calculated activity of radioiodine in hyperthyroidism. Design: Systematic review and meta-analysis. Methods: We searched the databases Medline. EMBASE. Web of Science, and Cochrane Library for randomized and nonrandomized Studies, comparing the effect of activity estimation methods with dosimetry for hyperthyroidism. The main outcome measure was the frequency of treatment success, defined as persistent euthyroidism after radioiodine treatment at the end of follow-up in the dose estimated and calculated dosimetry group. Furthermore, we assessed the Cure rates of hyperthyroidism. Results: Three randomized and live nonrandomized studies, comparing the effect of estimated versus calculated activity of radioiodine Oil Clinical Outcomes for the treatment of hyperthyroidism. were included. The weighted mean relative frequency of successful treatment outcome (euthyroidism) was 1.03 (95% confidence interval (CI) 0.91-1.16) for estimated versus calculated activity: the weighted mean relative frequency of cure of hyperthyroidism (eu- or hypothyroidism) wits 1.03 (95% CI 0.96-1.10). Subgroup analysis showed a relative frequency of euthyroidism of 1.03 (95% CI 0.84-1.26) for Graves' disease and of 1.05 (95% CI 0.91-1.19) for toxic multinodular goiter. Conclusion: The two main methods used to determine the activity in the treatment of hyperthyroidism with radioiodine, estimated and calculated. resulted in an equally Successful treatment outcome. However, the heterogeneity of the included studies is it strong limitation that prevents it definitive conclusion from this meta-analysis.